Vicore Pharma Holding AB
Nasdaq Stockholm · LEI 549300KTNBPTZLF01130· Fiscal year 2025
Staff cost per employee
Not disclosed
Employees
Not disclosed
Quick read
- Revenue fell 96.5% year over year.
- Operating loss of $44.4M in 2025.
Last 3 years
Revenue
Operating income
See the share price on Google Finance ↗
Investor metrics
2025
- Operating margin
- -11851.9%
- Net margin
- -12509.1%
- ROE
- -43.6%
- Debt-to-equity
- 11.2%
- Equity ratio
- 89.9%